{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:24:30Z","timestamp":1774121070580,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1056,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.rmed.2010.05.018","type":"journal-article","created":{"date-parts":[[2010,7,2]],"date-time":"2010-07-02T04:52:15Z","timestamp":1278046335000},"page":"1396-1403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD"],"prefix":"10.1016","volume":"104","author":[{"given":"Antonio","family":"Anzueto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Miravitlles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2010.05.018_bib1","first-page":"248","article-title":"Canadian guidelines for the management of acute exacerbations of chronic bronchitis: executive summary","volume":"10","author":"Balter","year":"2003","journal-title":"Can Respir J"},{"key":"10.1016\/j.rmed.2010.05.018_bib2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2010.05.018_bib3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"Soler-Catalu\u00f1a","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2010.05.018_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/thx.2003.008730","article-title":"Effect of exacerbations impair quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow-up study","volume":"59","author":"Miravitlles","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2010.05.018_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.rmed.2006.07.010","article-title":"Patient\u2019s perception of exacerbations of COPD\u2014the PERCEIVE study","volume":"101","author":"Miravitlles","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2010.05.018_bib6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1513\/pats.200701-003FM","article-title":"Exacerbations of chronic obstructive pulmonary disease","volume":"4","author":"Anzueto","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.rmed.2010.05.018_bib7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rmed.2010.05.018_bib8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2147\/COPD.S4257","article-title":"Geographic differences in clinical characteristics and management of COPD: the EPOCA study","volume":"3","author":"Miravitlles","year":"2008","journal-title":"Int J Chron Obstruc Pulmon Dis"},{"key":"10.1016\/j.rmed.2010.05.018_bib9","doi-asserted-by":"crossref","first-page":"380S","DOI":"10.1378\/chest.117.5_suppl_2.380S","article-title":"Infectious etiology of acute exacerbations of chronic bronchitis","volume":"17","author":"Sethi","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2010.05.018_bib10","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","article-title":"Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations","volume":"173","author":"Papi","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2010.05.018_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1378\/chest.116.1.40","article-title":"Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD","volume":"116","author":"Miravitlles","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2010.05.018_bib12","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1378\/chest.117.6.1638","article-title":"Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD","volume":"117","author":"Stockley","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2010.05.018_bib13","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1378\/chest.113.6.1542","article-title":"Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function","volume":"113","author":"Eller","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2010.05.018_bib14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1034\/j.1399-3003.2000.16d19.x","article-title":"Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease","volume":"16","author":"Seemungal","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2010.05.018_bib15","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1164\/ajrccm.161.5.9908022","article-title":"Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease","volume":"161","author":"Seemungal","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2010.05.018_bib16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.7326\/0003-4819-134-7-200104030-00015","article-title":"Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease","volume":"134","author":"Snow","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rmed.2010.05.018_bib17","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1378\/chest.117.5.1345","article-title":"Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD","volume":"117","author":"Adams","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2010.05.018_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/1753465807082692","article-title":"Do we need new antibiotics for treating exacerbations of COPD?","volume":"1","author":"Miravitlles","year":"2007","journal-title":"Ther Adv Respir Dis"},{"issue":"Suppl. B","key":"10.1016\/j.rmed.2010.05.018_bib19","first-page":"5B","article-title":"Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease\u20142007 update","volume":"14","author":"O\u2019Donnell","year":"2007","journal-title":"Can Respir J"},{"key":"10.1016\/j.rmed.2010.05.018_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1157\/13115749","article-title":"Antimicrobial treatment of exacerbation in chronic obstructive pulmonary disease: 2007 consensus statement","volume":"44","author":"Miravitlles","year":"2008","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.rmed.2010.05.018_bib21","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1183\/09031936.05.00055705","article-title":"Guidelines for the management of adult lower respiratory tract infections","volume":"26","author":"Woodhead","year":"2005","journal-title":"Eur Respir J"},{"issue":"7A","key":"10.1016\/j.rmed.2010.05.018_bib22","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1016\/j.amjmed.2005.05.012","article-title":"Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis","volume":"118","author":"Martinez","year":"2005","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.rmed.2010.05.018_bib23","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1183\/09031936.00003309","article-title":"Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study","volume":"34","author":"Garcia-Vidal","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2010.05.018_bib24","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1164\/rccm.200709-1413OC","article-title":"Pseudomonas aeruginosa in chronic obstructive pulmonary disease","volume":"177","author":"Murphy","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2010.05.018_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002512-200118010-00001","article-title":"Acute exacerbations of chronic bronchitis. What role for the new fluoroquinolones?","volume":"18","author":"Obaji","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.rmed.2010.05.018_bib26","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/jac\/dkn201","article-title":"Siempos II. Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis","volume":"62","author":"Falagas","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.rmed.2010.05.018_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/rmed.1999.0708","article-title":"Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis","volume":"94","author":"Chodosh","year":"2000","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2010.05.018_bib28","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1517\/14656566.9.10.1755","article-title":"Moxifloxacin: a respiratory fluoroquinolone","volume":"9","author":"Miravitlles","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.rmed.2010.05.018_bib29","first-page":"597","article-title":"Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB)","volume":"14","author":"Grassi","year":"2002","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.rmed.2010.05.018_bib30","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.clinthera.2006.08.013","article-title":"Levofloxacin 750 mg QD for five days versus amoxicillin\/clavulanate 875\u00a0mg\/125\u00a0mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: a post hoc analysis of data from severely ill patients","volume":"28","author":"Grossman","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.rmed.2010.05.018_bib31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/thorax.58.7.589","article-title":"Time course of recovery of health status following an infective exacerbation of chronic bronchitis","volume":"58","author":"Spencer","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2010.05.018_bib32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1378\/chest.125.3.953","article-title":"Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis","volume":"125","author":"Wilson","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2010.05.018_bib33","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.rmed.2010.05.018_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/thx.2007.090613","article-title":"Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies","volume":"63","author":"El Moussaoui","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2010.05.018_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1128\/AAC.49.1.153-160.2005","volume":"49","author":"Sethi","year":"2005","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1016\/j.rmed.2010.05.018_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1185\/030079905X26243","article-title":"Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis","volume":"21","author":"Gotfried","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.rmed.2010.05.018_bib37","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0924-8579(01)00435-6","article-title":"Randomized, double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis","volume":"18","author":"Masterton","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.rmed.2010.05.018_bib38","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1183\/09031936.05.00106404","article-title":"Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750\u00a0mg","volume":"25","author":"Martinez","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2010.05.018_bib39","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.rmed.2006.01.013","article-title":"Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort","volume":"100","author":"Urueta-Robledo","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2010.05.018_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijantimicag.2003.09.012","article-title":"Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis","volume":"23","author":"Starakis","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.rmed.2010.05.018_bib41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijantimicag.2006.08.043","article-title":"Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis","volume":"29","author":"Zervos","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.rmed.2010.05.018_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/thx.2005.045930","article-title":"Antibiotic treatment and factors influencing short and long-term outcomes of acute exacerbations of chronic bronchitis","volume":"61","author":"Wilson","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2010.05.018_bib43","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.rmed.2004.03.028","article-title":"A randomized, double-blind study comparing 5 days oral gemifloxacin with 7 days oral levofloxacin in patients with acute exacerbation of chronic bronchitis","volume":"98","author":"Sethi","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2010.05.018_bib44","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0149-2918(02)85139-6","article-title":"A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes","volume":"24","author":"Wilson","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.rmed.2010.05.018_bib45","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1179\/joc.2000.12.4.314","article-title":"Gemifloxacin versus amoxicillin\/clavulanate in the treatment of acute exacerbations of chronic bronchitis","volume":"12","author":"File","year":"2000","journal-title":"J Chemother"},{"key":"10.1016\/j.rmed.2010.05.018_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00044011-200323070-00003","article-title":"Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials","volume":"23","author":"Miravitlles","year":"2003","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.rmed.2010.05.018_bib47","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.rmed.2005.01.013","article-title":"Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease","volume":"99","author":"Miravitlles","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2010.05.018_bib48","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/00044011-200626120-00007","article-title":"Real-life treatment of acute exacerbations of chronic bronchitis with moxifloxacin or macrolides","volume":"26","author":"Schaberg","year":"2006","journal-title":"Clin Drug Investig"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611110002544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611110002544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:00:33Z","timestamp":1760612433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611110002544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0954611110002544"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2010.05.018","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2010.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}